By Cecilia Butini

Merck KGaA said Monday that it would reorganize its growth-driving life-sciences division and that it would add new business units.

The German pharmaceuticals-and-chemicals company said it would integrate its existing contract-development and manufacturing organization and contract-testing services into one unit, named life science services. This will include the company's mRNA output, which is used in the development of some Covid-19 vaccines.

Merck's research-solutions and applied-solutions business units will also be merged into one, named science and lab solutions, the company said.

Write to Cecilia Butini at cecilia.butini@wsj.com

(END) Dow Jones Newswires

February 07, 2022 09:45 ET (14:45 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Merck KGAA (TG:MRK)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Merck KGAA.
Merck KGAA (TG:MRK)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Merck KGAA.